vs
Side-by-side financial comparison of NICOLET BANKSHARES INC (NIC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
NICOLET BANKSHARES INC is the larger business by last-quarter revenue ($104.0M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.5%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 12.5%).
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NIC vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.0M | $75.5M |
| Net Profit | $40.3M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 48.3% | 22.7% |
| Net Margin | 38.8% | — |
| Revenue YoY | 12.5% | 27.7% |
| Net Profit YoY | 16.9% | — |
| EPS (diluted) | $2.63 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.0M | $75.5M | ||
| Q3 25 | $102.9M | $54.5M | ||
| Q2 25 | $95.7M | $52.4M | ||
| Q1 25 | $89.4M | $46.0M | ||
| Q4 24 | $92.4M | $59.1M | ||
| Q3 24 | $90.7M | $80.5M | ||
| Q2 24 | $85.0M | $47.1M | ||
| Q1 24 | $82.2M | $43.8M |
| Q4 25 | $40.3M | — | ||
| Q3 25 | $41.7M | $8.8M | ||
| Q2 25 | $36.0M | $5.9M | ||
| Q1 25 | $32.6M | $3.0M | ||
| Q4 24 | $34.5M | — | ||
| Q3 24 | $32.5M | $20.3M | ||
| Q2 24 | $29.3M | $-4.5M | ||
| Q1 24 | $27.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 48.3% | 22.7% | ||
| Q3 25 | 50.4% | 17.6% | ||
| Q2 25 | 46.8% | 12.7% | ||
| Q1 25 | 44.9% | 8.7% | ||
| Q4 24 | 46.8% | 22.6% | ||
| Q3 24 | 45.0% | 27.4% | ||
| Q2 24 | 43.3% | -4.6% | ||
| Q1 24 | 41.8% | -5.3% |
| Q4 25 | 38.8% | — | ||
| Q3 25 | 40.6% | 16.2% | ||
| Q2 25 | 37.6% | 11.2% | ||
| Q1 25 | 36.4% | 6.5% | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 35.8% | 25.2% | ||
| Q2 24 | 34.5% | -9.6% | ||
| Q1 24 | 33.8% | -11.0% |
| Q4 25 | $2.63 | $0.26 | ||
| Q3 25 | $2.73 | $0.17 | ||
| Q2 25 | $2.34 | $0.12 | ||
| Q1 25 | $2.08 | $0.06 | ||
| Q4 24 | $2.21 | $0.40 | ||
| Q3 24 | $2.10 | $0.41 | ||
| Q2 24 | $1.92 | $-0.09 | ||
| Q1 24 | $1.82 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $134.9M | $22.7M |
| Stockholders' EquityBook value | $1.3B | $130.3M |
| Total Assets | $9.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.11× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $134.9M | $22.7M | ||
| Q3 25 | $134.6M | $34.0M | ||
| Q2 25 | $134.3M | $45.3M | ||
| Q1 25 | $156.6M | $56.7M | ||
| Q4 24 | $161.4M | $68.0M | ||
| Q3 24 | $161.2M | $79.3M | ||
| Q2 24 | $162.4M | $90.7M | ||
| Q1 24 | $162.3M | $102.0M |
| Q4 25 | $1.3B | $130.3M | ||
| Q3 25 | $1.2B | $115.3M | ||
| Q2 25 | $1.2B | $104.7M | ||
| Q1 25 | $1.2B | $97.1M | ||
| Q4 24 | $1.2B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.1B | $48.5M | ||
| Q1 24 | $1.1B | $51.0M |
| Q4 25 | $9.2B | $216.3M | ||
| Q3 25 | $9.0B | $202.9M | ||
| Q2 25 | $8.9B | $194.9M | ||
| Q1 25 | $9.0B | $196.2M | ||
| Q4 24 | $8.8B | $213.3M | ||
| Q3 24 | $8.6B | $220.7M | ||
| Q2 24 | $8.6B | $205.0M | ||
| Q1 24 | $8.4B | $214.1M |
| Q4 25 | 0.11× | 0.17× | ||
| Q3 25 | 0.11× | 0.30× | ||
| Q2 25 | 0.11× | 0.43× | ||
| Q1 25 | 0.13× | 0.58× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.14× | 1.12× | ||
| Q2 24 | 0.15× | 1.87× | ||
| Q1 24 | 0.15× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $153.5M | $14.4M |
| Free Cash FlowOCF − Capex | $149.4M | $14.4M |
| FCF MarginFCF / Revenue | 143.7% | 19.1% |
| Capex IntensityCapex / Revenue | 3.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | $275.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $153.5M | $14.4M | ||
| Q3 25 | $45.9M | $9.7M | ||
| Q2 25 | $38.9M | $14.1M | ||
| Q1 25 | $41.8M | $3.6M | ||
| Q4 24 | $133.7M | $15.6M | ||
| Q3 24 | $39.6M | $11.0M | ||
| Q2 24 | $37.3M | $1.0M | ||
| Q1 24 | $23.4M | $11.2M |
| Q4 25 | $149.4M | $14.4M | ||
| Q3 25 | $45.9M | $9.7M | ||
| Q2 25 | $38.4M | $14.1M | ||
| Q1 25 | $41.3M | $3.6M | ||
| Q4 24 | $116.8M | $15.6M | ||
| Q3 24 | $34.7M | $11.0M | ||
| Q2 24 | $34.4M | $1.0M | ||
| Q1 24 | $20.1M | — |
| Q4 25 | 143.7% | 19.1% | ||
| Q3 25 | 44.6% | 17.7% | ||
| Q2 25 | 40.1% | 26.8% | ||
| Q1 25 | 46.2% | 7.7% | ||
| Q4 24 | 126.4% | 26.4% | ||
| Q3 24 | 38.3% | 13.7% | ||
| Q2 24 | 40.5% | 2.1% | ||
| Q1 24 | 24.4% | — |
| Q4 25 | 3.9% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 18.3% | 0.0% | ||
| Q3 24 | 5.4% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% | ||
| Q1 24 | 4.0% | 0.0% |
| Q4 25 | 3.81× | — | ||
| Q3 25 | 1.10× | 1.10× | ||
| Q2 25 | 1.08× | 2.41× | ||
| Q1 25 | 1.28× | 1.21× | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.22× | 0.54× | ||
| Q2 24 | 1.28× | — | ||
| Q1 24 | 0.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
